Substrates for peptidase C03.007: human rhinovirus 2-type picornain 3C

Summary Alignment Tree Sequences Sequence features Distribution Structure Literature Substrates Pharma

Peptide and protein substrates that are thought to be physiologically relevant are indicated by P. Peptide and protein substrates that are thought to be pathologically relevant are indicated by D. Peptide and protein substrates that are not physiologically relevant are indicated by N. Synthetic substrates are indicated by S. Click on the symbol to show only physiological, non-physiological or synthetic substrates, or here to display all substrates. How cleavage sites have been identified are indicated by the following evidence codes: NT = N-terminal sequencing, MS = mass spectroscopy, MU = mutation, CS = consensus sequence, LC = liquid chromatography. To see all annotated cleavages for a protein substrate, click on the UniProt Accession.

Substrate	Uniprot	Residue range	Cleavage Site	Cleavage type	P4	P3	P2	P1	P1'	P2'	P3'	P4'	Reference	CutDB
polyprotein	P04936	2-2150	peptide-Gln330+Gly-peptide	P	Ala	Lys	Arg	Gln	Gly	Leu	Pro	Val	Skern, 2004	16149
polyprotein	P04936	2-2150	peptide-Gln992+Gly-peptide	P	Ala	Glu	Glu	Gln	Gly	Val	Thr	Asp	Skern, 2004	16150
polyprotein	P04936	2-2150	peptide-Gln1409+Gly-peptide	P	Ala	Ile	Phe	Gln	Gly	Pro	Ile	Asp	Skern, 2004	16145
polyprotein	P04936	2-2150	peptide-Gln1486+Gly-peptide	P	Cys	Thr	Leu	Gln	Gly	Pro	Tyr	Ser	Skern, 2004	16146
polyprotein	P04936	2-2150	peptide-Gln1507+Gly-peptide	P	Val	Val	Thr	Gln	Gly	Pro	Glu	Glu	Skern, 2004	16147
polyprotein	P04936	2-2150	peptide-Gln1690+Gly-peptide	P	Thr	Asp	Val	Gln	Gly	Gln	Ile	Thr	Skern, 2004	16148